BIO hosted their annual Legislative Day Fly-In this past April 3-4, 2019. The two-day event convened biotechnology executives from across the country in Washington, D.C. for legislative briefings and advocacy.
RI Bio and other members of the Council of State Bioscience Associations (CSBA) engaged with Members of Congress along with their senior staff on the most important legislative policy issues facing the biotechnology industry. Attendees met in small groups with the Congressional Members and senior staff of the attendee’s Congressional Delegation. Medley Genomics and Ximedica joined RI Bio on the Hill this year.
As a member of the Council of State Bioscience Associations, RI Bio plays an integral role in the shared mission to advocate for policies that spur innovation, patient access to new medicines and good jobs in Rhode Island and across the country. “To build Rhode Island’s life sciences industry requires collaboration and unified commitment from the federal, state, academic institutions and private sectors,” said Carol Malysz, executive director, RI Bio. “We are here with our member companies to support this commitment by advocating for policies and resources that can advance the life sciences economy in our state.”